Stay updated with breaking news from Hyperfine Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyperfine (NASDAQ:HYPR – Get Rating) had its price target cut by B. Riley from $3.50 to $2.50 in a research report released on Wednesday, The Fly reports. They currently have a buy rating on the stock. B. Riley also issued estimates for Hyperfine’s Q1 2023 earnings at ($0.16) EPS, Q2 2023 earnings at ($0.16) EPS, […]
Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) – Equities research analysts at B. Riley boosted their FY2023 earnings per share (EPS) estimates for Hyperfine in a research note issued to investors on Tuesday, March 21st. B. Riley analyst N. Chatterji now anticipates that the company will earn ($0.67) per share for the year, up from their […]
Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the brain, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software.
Latest Swoop® software improves image quality for DWI imaging of the brain...
New study utilizes Hyperfine, Inc. portable MRI system in monitoring brain injury and evaluating physiological impacts...